美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=ALOGLIPTIN"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
ALOGLIPTIN; METFORMIN HYDROCHLORIDE 210160 001 ANDA ALOGLIPTIN; METFORMIN HYDROCHLORIDE TABLET;ORAL EQ 12.5MG BASE;500MG No 2018/12/19 (TA) TORRENT PHARMS LTD None (Tentative Approval)
ALOGLIPTIN; METFORMIN HYDROCHLORIDE 210160 002 ANDA ALOGLIPTIN; METFORMIN HYDROCHLORIDE TABLET;ORAL EQ 12.5MG BASE;1GM No 2018/12/19 (TA) TORRENT PHARMS LTD None (Tentative Approval)
ALOGLIPTIN 210213 001 ANDA ALOGLIPTIN BENZOATE TABLET;ORAL EQ 6.25MG BASE No 2019/01/29 (TA) MSN LABS PVT LTD None (Tentative Approval)
ALOGLIPTIN 210213 002 ANDA ALOGLIPTIN BENZOATE TABLET;ORAL EQ 12.5MG BASE No 2019/01/29 (TA) MSN LABS PVT LTD None (Tentative Approval)
ALOGLIPTIN 210213 003 ANDA ALOGLIPTIN BENZOATE TABLET;ORAL EQ 25MG BASE No 2019/01/29 (TA) MSN LABS PVT LTD None (Tentative Approval)
ALOGLIPTIN AND METFORMIN HYDROCHLORIDE 210212 001 ANDA ALOGLIPTIN AND METFORMIN HYDROCHLORIDE TABLET; ORAL 12.5MG/500MG No 2019/11/27 (TA) MSN LABORATORIES PRIVATE LTD None (Tentative Approval)
ALOGLIPTIN AND METFORMIN HYDROCHLORIDE 210212 002 ANDA ALOGLIPTIN AND METFORMIN HYDROCHLORIDE TABLET; ORAL 12.5MG/1000MG No 2019/11/27 (TA) MSN LABORATORIES PRIVATE LTD None (Tentative Approval)
ALOGLIPTIN 210002 001 ANDA ALOGLIPTIN BENZOATE TABLET;ORAL 6.25MG No 2019/12/23 (TA) INDOCO REMEDIES None (Tentative Approval)
药品名称,活性成分,申请号搜索 高级检索
©2006-2020 DrugFuture->U.S. FDA Drugs Database